Key takeaways:
Atrial fibrillation (AFib) is the most common abnormal heart rhythm (arrhythmia). When untreated, it can have serious complications, like stroke and heart failure.
Amiodarone is a commonly used medication to treat AFib.
Amiodarone is associated with toxicity to organs such as the liver, thyroid, lungs, heart, and nervous system. Careful monitoring can reduce the risk of damage to other organs.
Atrial fibrillation (AFib) is the most common arrhythmia (abnormal heart beat) diagnosed in the U.S. every year. And about 37 million people have AFib around the world.
AFib can have serious complications, such as stroke and heart failure. So, it’s important to keep the heart in a normal range and rhythm to minimize risk. Medications like amiodarone (Pacerone) help the heart stay in a normal rhythm. This is especially true in people with underlying heart problems, like heart failure.
Let’s take a closer look at how amiodarone works and how it can be used safely.
In most cases, yes: Amiodarone is safe when you use it correctly. But it does need careful monitoring due to the risk of serious side effects. Amiodarone can cause damage to certain organs and tissues (more on this below). Regular checkups can prevent complications.
The decision to take amiodarone comes down to you and a healthcare professional who knows your medical history. The main question to ask is: Does the benefit of taking amiodarone outweigh the risk of side effects? This all depends on factors like:
Your specific heart problem
Other medical issues you may have
The other medications you may take
Your access to healthcare
Atrial fibrillation (AFib) is the most common heart rhythm diagnosis in the U.S.: Learn about its causes and triggers so you can minimize your risk.
Did you know that AFib increases the risk of stroke? Luckily, blood thinners can help reduce the risk of clotting that leads to stroke.
Decoding heart arrhythmias: This guide to arrhythmias explains the types, causes, and treatments for abnormal heart rhythms.
Amiodarone works mainly on potassium channels in the electrical system of the heart. When potassium channels are blocked, the electrical conduction system of the heart slows down. This is what makes amiodarone useful for treating the irregular heart rhythm with AFib.
Amiodarone is one of the most commonly used medications to treat AFib. But the FDA hasn’t approved it yet for AFib treatment — so prescribers usually reserve it for specific situations.
Let’s review the two main treatments for AFib.
The most common symptoms of AFib are linked to a fast heart rate, like:
Palpitations
Shortness of breath
Lightheadedness
In these cases, slowing the heart rate can help. Beta blockers and calcium channel blockers are useful medications for rate control. Healthcare professionals sometimes use amiodarone for rate control. But it isn’t as fast and effective as beta blockers and calcium channel blockers.
If the medications mentioned above aren’t working well, or you still have symptoms, then rhythm control medications can be useful. Rhythm control medications convert the heart from AFib back into a normal rhythm — and keep it there.
Amiodarone is an example of a rhythm control medication. Others include:
Amiodarone is the most effective AFib medication when the goal is to restore and keep the heart in its normal rhythm. That’s the position of leading heart organizations like the American Heart Association and American College of Cardiology. Researchers have extensively tested amiodarone against rhythm control medications like sotalol, flecainide, and propafenone.
Studies show that amiodarone works better to keep AFib away. In one study, 65% of people taking amiodarone maintained their normal heart rhythms. That’s compared to about 40% of those taking other rhythm control medications.
The dose of amiodarone that’s right for you depends on your medical history and heart problems.
If a healthcare professional prescribes you amiodarone outside of a hospital, you’ll likely take a higher dose for a few weeks so that it can build up in your system. Then you’ll take a lower maintenance dose every day, typically between 100 mg and 200 mg.
Remember: Amiodarone doses can vary from person to person. So be sure to check with your prescriber’s office or pharmacist if you have questions.
Rhythm control medications work well to keep the heart in a normal rhythm. But the tradeoff is the risk of increased side effects. And when it comes to side effects and toxicity, amiodarone has one of the worst track records.
The good news is that there’s a lot of research on how to safely use amiodarone. We’ll summarize the main points here.
Side effects from amiodarone happen quite often. In the first year, 15% of people experience them. With long-term use, they affect half of people.
But compared to other rhythm control medications, amiodarone is associated with fewer cardiac emergencies, such as arrhythmia and sudden cardiac arrest. So, for many people, the tradeoff is worthwhile — especially since there are ways to prescribe and take amiodarone safely (more on this below).
Nearly everyone who takes amiodarone gets microdeposits on the cornea of the eye. For most people, this doesn’t cause any problems. But some people can develop halo vision and light sensitivity.
There are other important risks to consider as well. Research shows that people who took amiodarone had significantly higher rates of serious damage to these organs:
Thyroid (overactive or underactive thyroid disease)
Liver (elevated liver enzymes and jaundice)
Lung (lung scarring and other serious lung conditions)
Heart (heart conduction system abnormalities and dangerously low heart rates)
Neurological system (peripheral neuropathy and cognitive impairment)
Skin (blue skin discoloration and sensitivity to the sun)
Pregnant people should also avoid amiodarone, as it can lead to thyroid and neurological issues in the developing pregnancy.
Amiodarone can become toxic. That’s because it can easily enter various tissues of the body, like fat and muscle. And it can enter organs, like the liver and lung. Amiodarone and its main byproduct, desethylamiodarone, can then accumulate in these tissues. And it can remain in the body for several months. This can happen even after you stop the medication.
Researchers don’t know exactly how amiodarone causes damage. And the damage may differ from one organ to the next. In the lung, for example, amiodarone may cause the immune system to attack lung tissue. It can also cause direct damage to lung cells. Also, amiodarone contains iodine and has many structural similarities to thyroid hormones. So, it can cause both overactive and underactive thyroid conditions.
Amiodarone side effects can range from being a minor nuisance to a serious threat that leads to permanent organ damage. Mild side effects can occur within a few days to weeks, including:
Fatigue
Nausea
Constipation
Headache
Loss of appetite
Mild side effects from amiodarone may settle over time and not be a cause for concern. But if symptoms persist, it may be a sign of something more serious, such as one or more of the organ toxicities discussed above.
If you have questions or concerns about side effects, especially if you’ve recently started amiodarone, reach out to your prescriber.
Yes — amiodarone interacts with several medications. Some common examples are:
Procainamide
Some calcium channel blockers
Some beta blockers
Here’s a complete list of amiodarone interactions.
Medication interactions with amiodarone can cause serious complications, like slow heart rates, decreased blood pressure, and increased medication levels. That’s why it’s important to go over your full medication list with your prescriber and the pharmacist who fills your prescriptions.
It’s possible to stay safe when taking amiodarone. People have been taking amiodarone for decades, so there’s a lot of shared experience to draw from.
Here’s how to make sure you stay safe and healthy when taking amiodarone:
Take the lowest effective dose. Studies show that low-dose (200 mg daily or less) and very low-dose (100 mg daily or less) amiodarone cause less toxicity than higher doses of amiodarone. If you’re taking over 200 mg daily, check with your prescriber to confirm that’s the lowest dose needed to treat your AFib.
Take it for the shortest time necessary. Sometimes, people need amiodarone for a period of weeks or months, like after heart surgery. Check with your healthcare team to find out how long you’ll need to take amiodarone.
Monitor your thyroid, liver, and lungs. You need thyroid and liver blood tests before you start amiodarone and every 6 months while you take it. You also need lung function tests and chest X-rays before and during amiodarone use.
Check in frequently with your healthcare team. Stay in close contact with your primary care provider and cardiologist so they can monitor your electrocardiogram (ECG or EKG) and check you for side effects.
Visit your pharmacist. You should go over your medication list because amiodarone has many medication interactions.
Your prescriber may need to adjust your amiodarone dose, depending on how your heart tolerates the medication and if you have any side effects.
If you can’t tolerate amiodarone, or if you have a medical condition that doesn’t allow you to take it, there are several other options for AFib treatment.
Dronedarone is a medication that’s very similar to amiodarone, but it doesn’t contain iodine. As a result, dronedarone isn’t associated with most of the non-cardiac side effects of amiodarone. But it’s not as effective as amiodarone for decreasing AFib. And its use is linked to higher death rates in people with heart failure.
Rate control medications, such as beta blockers and calcium channel blockers, are common in the treatment of AFib. Rhythm control medications, such as dofetilide, are also common, especially in people who have heart failure.
Remember never to stop a heart medication — including amiodarone — until you discuss your concerns with your healthcare team.
Yes, most cases of amiodarone toxicity can be reversed. Organ damage can be reversed by doing the following:
Stopping amiodarone therapy at the first signs of toxicity
Taking steroids for 4 to 12 months
It’s important for you and your prescriber to monitor for any symptoms of organ toxicity so that amiodarone can be stopped as quickly as possible.
AFib can result from many different cardiac, medical, and lifestyle factors. Some of the more common cardiac reasons for AFib include:
Heart failure
Heart valve disease
Other medical factors are:
Advanced age
Family history
Thyroid issues
Obesity
Viral illnesses
Finally, lifestyle can play a role in AFib, such as with alcohol and drug use.
AFib causes the upper chamber of the heart (atrium) to squeeze inefficiently. This slows the rate of blood flow through the heart. And slow blood flow is more prone to forming clots. Once tiny clots are formed, they can travel to the brain, resulting in a stroke.
Amiodarone is a useful treatment for AFib. It has a low rate of heart-related complications. But amiodarone can build up in other tissues of the body and cause damage to organs like the lung, liver, and thyroid. Experts generally consider amiodarone to be safe. But it does require careful monitoring by a cardiologist and a primary care physician.
If a healthcare professional recommends amiodarone for AFib, talk about ways to stay safe. You can take the lowest dose possible and regularly review your medication list to avoid interactions.
Adams, P. C., et al. (1985). Amiodarone and its desethyl metabolite: Tissue distribution and morphologic changes during long-term therapy. Circulation.
American Heart Association. (2023). What is atrial fibrillation?
American Lung Association. (2024). Pulmonary function tests.
Baizabal-Carvallo, J. F., et al. (2022). Drug-induced tremor, clinical features, diagnostic approach and management. Journal of the Neurological Sciences.
Bargout, R., et al. (2000). Amiodarone induces apoptosis of human and rat alveolar epithelial cells in vitro. American Journal of Physiology Lung Cellular and Molecular Physiology.
Bartalena, L., et al. (2014). Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. Journal of Endocrinological Investigation.
Chokesuwattanaskul, R., et al. (2020). Low-dose amiodarone is safe: A systematic review and meta-analysis. The Journal of Innovations in Cardiac Rhythm Management.
Connolly, S. J. (1999). Evidence-based analysis of amiodarone efficacy and safety. Circulation.
Epstein, A. E., et al. (2016). Practical management guide for clinicians who treat patients with amiodarone. The American Journal of Medicine.
Florek, J. B., et al. (2023). Amiodarone. StatPearls.
Freedman, M. D., et al. (1991). Pharmacology and pharmacokinetics of amiodarone. The Journal of Clinical Pharmacology.
Freemantle, N., et al. (2011). Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. EP Europace.
Goldschlager, N., et al. (2000). Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. JAMA Internal Medicine.
Hollander, D. A., et al. (2004). Drug-induced corneal complications. Current Opinion in Ophthalmology.
January, C. T., et al. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Circulation.
Karpel, J. P., et al. (1991). Natural killer cell activity in a rat model of amiodarone-induced interstitial lung disease. Chest.
Køber, L., et al. (2008). Increased mortality after dronedarone therapy for severe heart failure. The New England Journal of Medicine.
Lafuente-Lafuente, C., et al. (2006). Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: A systematic review of randomized controlled trials. JAMA Internal Medicine.
Le Heuzey, J., et al. (2010). A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: The DIONYSOS study. Journal of Cardiovascular Electrophysiology.
Letelier, L. M., et al. (2003). Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: A meta-analysis. JAMA Internal Medicine.
Lippi, G., et al. (2020). Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. International Journal of Stroke.
Narayana, S. K., et al. (2011). Management of amiodarone-related thyroid problems. Therapeutic Advances in Endocrinology and Metabolism.
Patel, C., et al. (2009). Dronedarone. Circulation.
Roy, D., et al. (2000). Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. The New England Journal of Medicine.
Ruzieh, M., et al. (2019). Meta-analysis comparing the relative risk of adverse events for amiodarone versus placebo. The American Journal of Cardiology.
Siu, C., et al. (2009). Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. Critical Care Medicine.
Tse, H. F., et al. (2002). Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation. Clinical and Experimental Pharmacology and Physiology.
Vassallo, P., et al. (2007). Prescribing amiodarone: An evidence-based review of clinical indications. JAMA.
Wolkove, N., et al. (2009). Amiodarone pulmonary toxicity. Canadian Respiratory Journal.